Modulating NRF2 in Disease: Timing Is Everything

Area of Science:

• Molecular Biology
• Cellular Signaling
• Therapeutics Development

Background:

• Nuclear factor erythroid 2 (NF-E2)-related factor 2 (NRF2) is a master regulator of cellular homeostasis, impacting redox balance, metabolism, and protein stability.
• NRF2 signaling is intricately linked with numerous cellular pathways, highlighting its broad physiological relevance.
• Current therapeutic strategies targeting NRF2 are limited, with dimethyl fumarate being the sole approved drug for multiple sclerosis.

Purpose of the Study:

• To provide a comprehensive review of NRF2 pathway regulation and its downstream targets.
• To elucidate the multifaceted role of NRF2 in various diseases, including cancer, neurodegeneration, diabetes, and organ-specific pathologies.
• To highlight the potential and progress of NRF2-based therapeutics, including those in clinical trials.

Main Methods:

• Literature review and synthesis of existing research on NRF2.
• Analysis of NRF2's role in diverse pathological conditions.
• Examination of current and emerging NRF2-targeting therapeutic strategies.

Main Results:

• NRF2 is a critical node in cellular defense mechanisms against various stressors.
• Dysregulation of NRF2 is implicated in the pathogenesis of major diseases such as cancer, neurodegenerative disorders, and diabetes.
• Significant progress has been made in developing NRF2-modulating therapies, with several candidates progressing to clinical evaluation.

Conclusions:

• Precise modulation of the NRF2 pathway holds therapeutic promise across a spectrum of diseases.
• Further research into NRF2 regulation and its complex interactions is essential for optimizing therapeutic interventions.
• Targeting NRF2 represents a promising strategy for managing complex diseases and improving patient outcomes.